89488-25-5

Basic information

• Product Name: 5-CHLORO-2-HYDROXYPHENYLBORONIC ACID
• Synonyms: AKOS BRN-0742;5-CHLORO-2-HYDROXYPHENYLBORONIC ACID;5-CHLORO-2-HYDROXYBENZENEBORONIC ACID;5-Chloro-2-hydroxybenzeneboronic acid 97%;2-Borono-4-chlorophenol;Benzeneboronic acid, 5-chloro-2-hydroxy-;Boronic acid, B-(5-chloro-2-hydroxyphenyl)-;5-Chloro-2-hydroxybenzeneboronicacid97%
• CAS NO: 89488-25-5
• Molecular Formula: C₆H₆BClO₃
• Molecular Weight: 172.37
• Product Categories: blocks;BoronicAcids;Boronate Ester;Boronic Acid;Potassium Trifluoroborate
• Mol File: 89488-25-5.mol

Chemical Properties

• Melting Point: 166-170
• Boiling Point: 369.275 °C at 760 mmHg
• Flash Point: 177.131 °C
• Appearance: /
• Density: 1.492g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.602
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 7.63±0.58(Predicted)
• CAS DataBase Reference: 5-CHLORO-2-HYDROXYPHENYLBORONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 5-CHLORO-2-HYDROXYPHENYLBORONIC ACID(89488-25-5)
• EPA Substance Registry System: 5-CHLORO-2-HYDROXYPHENYLBORONIC ACID(89488-25-5)

Safety Data

• Hazard Codes: Xi
• Statements: 41
• Safety Statements: 26-39
• Hazardous Substances Data: 89488-25-5(Hazardous Substances Data)

Usage

Uses

suzuki reaction

InChI:InChI=1/C6H6BClO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9-11H

Upstream product

• 106-48-9 4-chloro-phenol 
• 121-43-7 Trimethyl borate 
• 826-26-6 1-chloro-4-(methoxymethoxy)benzene 
• 7732-18-5 water 
• 89694-48-4 5-chloro-2-methoxyphenyl boronic acid 
• 89466-08-0 2-hydroxyphenyl boronic acid 

Downstream Products

• 1235407-20-1 tert-Butyl 4-(4-(5-chloro-2-hydroxyphenyl)pyridin-2-yl)piperazine-1-carboxylate 
• 1354787-48-6 tert-Butyl 4-(4-(2-(benzyloxy)-5-chlorophenyl)pyridin-2-yl)piperazine-1-carboxylate 
• 1354787-47-5 tert-Butyl 4-(4-(4-(benzyloxy)-4'-(trifluoromethyl)biphenyl-3-yl)pyridin-2-yl)piperazine-1-carboxylate 
• 1354787-46-4 tert-butyl 4-(4-(4-hydroxy-4'-(trifluoromethyl)biphenyl-3-yl)pyridin-2-yl)piperazine-1-carboxylate 
• 1354787-52-2 tert-Butyl 4-(4-(4-(2-chloro-4-(N-(2,4-dimethoxybenzyl)-N-(pyrimidin-2-yl)sulfamoyl)-5-fluorophenoxy)-4'-(trifluoromethyl)biphenyl-3-yl)pyridin-2-yl)piperazine-1-carboxylate 
• 1354786-52-9 5-chloro-2-fluoro-4-{[3-(2-piperazin-1-ylpyridin-4-yl)-4'-(trifluoromethyl)biphenyl-4-yl]oxy}-N-pyrimidin-2-ylbenzenesulfonamide 
• 1354787-42-0 tert-butyl 4-(4-(4-(2-chloro-4-(N-(2,4-dimethoxybenzyl)-N-(pyrimidin-4-yl)sulfamoyl)-5-fluorophenoxy)-4'-(trifluoromethyl)biphenyl-3-yl)pyridin-2-yl)piperazine-1-carboxylate 
• 1354786-47-2 5-Chloro-2-fluoro-4-({3-[2-(piperazin-1-yl)pyridin-4-yl]-4'-(trifluoromethyl)biphenyl-4-yl}oxy)-N-(pyrimidin-4-yl)benzenesulfonamide hydrochloride salt 
• 1354787-45-3 tert-Butyl 4-(4-(4-(2-chloro-4-(N-(2,4-dimethoxybenzyl)-N-(1,3,4-thiadiazol-2-yl)sulfamoyl)-5-fluorophenoxy)-4'-(trifluoromethyl)biphenyl-3-yl)pyridin-2-yl)piperazine-1-carboxylate 
• 956124-97-3 {(R)-2-[2-(5-chloro-2-hydroxy-phenyl)-pyrimidin-4-ylamino]-1-methyl-ethyl}-carbamic acid benzyl ester 
• 956125-03-4 4-chloro-2-(4-chloro-quinolin-2-yl)-phenol 

Relevant articles and documents

Enantiodivergent Atroposelective Synthesis of Chiral Biaryls by Asymmetric Transfer Hydrogenation: Chiral Phosphoric Acid Catalyzed Dynamic Kinetic Resolution

Reported herein is an enantiodivergent synthesis of chiral biaryls by a chiral phosphoric acid catalyzed asymmetric transfer hydrogenation reaction. Upon treatment of biaryl lactols with aromatic amines and a Hantzsch ester in the presence of chiral phosp

SELECTIVE NAV1.7 INHIBITORS FOR THE TREATMENT OF DIABETES

Provided herein are methods for treating or preventing prediabetes or diabetes, or maintaining or lowering blood or plasma glucose or maintaining or lowering blood or plasma glycated hemoglobin comprising administering to a subject in need thereof a therapeutically effective amount of a compound selectively inhibiting NaVl.7. In particular, provided herein are processes for the preparation of and intermediates used in the preparation of compounds selectively inhibiting NaV1.7, such as the compounds of Formula (I) or compounds of Formula (I').

SODIUM CHANNEL MODULATORS FOR THE TREATMENT OF PAIN AND DIABETES

Provided herein are sodium channel modulating Compounds, in particular NaV1.7 modulating compounds of Formula I or compounds of Formula I′: In particular, provided herein are processes for the preparation of, intermediates used in the preparation of, pharmaceutical compositions comprising, and therapeutic methods comprising administering such compounds. In particular, provided herein are compounds for the treatment of pain and diabetes.

SODIUM CHANNEL MODULATORS FOR THE TREATMENT OF PAIN

Provided herein are sodium channel modulating Compounds, in particular NaV1.7 modulating compounds of Formula I: In particular, provided herein are processes for the preparation of, intermediates used in the preparation of, pharmaceutical compositions comprising, and therapeutic methods comprising administering such compounds. In particular, provided herein are compounds for the treatment of pain.

Rh/Pd catalysis with chiral and achiral ligands: Domino synthesis of aza-dihydrodibenzoxepines

A game of dominoes: A synthetic route to aza-dihydrodibenzoxepines is described, through the combination of a Rh-catalyzed arylation and a Pd-catalyzed C-O coupling in a single pot. For the first time, the ability to incorporate a chiral and an achiral ligand in a two-component, two-metal transformation is achieved, giving the products in moderate to good yields, with excellent enantioselectivities. Copyright